Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Memorial Sloan Kettering Cancer Center
Sponsor:
Collaborators:
Colon and Rectal Surgery Inc.
The Cleveland Clinic
John Muir Health
Oregon Health and Science University
St. Joseph Hospital of Orange
University of Calgary
University of California, Irvine
University of California, San Francisco
University of Chicago
University of South Florida
University of Vermont
University of Washington
Washington Hospital Center
Washington University School of Medicine
Bergan Mercy Medical Centere
The Methodist Hospital System
University of Rochester
University of Virginia
St. Paul's Hospital
St. Joseph, Florida
Cleveland Clinic Florida
University of Colorado, Aurora
University of Michigan
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT02008656
First received: November 27, 2013
Last updated: November 17, 2016
Last verified: November 2016